Last reviewed · How we verify

NCT03905187

Stress Management Modified Cardiac Rehabilitation in Patients After Acute Myocardial Infarction or Heart Failure

Status unknown NA Last updated 10 April 2019
What this trial tests

NA trial testing Modified CR in Acute Myocardial Infarction in 1,200 participants. Status unknown.

Timeline
16 April 2019
Primary endpoint
1 September 2021
1 September 2021

Quick facts

Lead sponsorJing Ma
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment1,200
Start date16 April 2019
Primary completion1 September 2021
Estimated completion1 September 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Jing Ma — full company profile →

Who can join

Adults 18 to 80, any sex, with Acute Myocardial Infarction or Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purposes of this study is to evaluate the improvement of a stress management involved cardiac rehabilitation program on the psychological states, quality of life and clinical outcomes of patients after acute myocardial infarction or heart failure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exercise-based cardiac rehabilitation for coronary heart disease.
    Dibben G, Faulkner J, Oldridge N, Rees K, et al · · 2021 · cited 323× · PMID 34741536 · DOI 10.1002/14651858.cd001800.pub4

Verify or expand the search:

Other recruiting trials for Acute Myocardial Infarction

Currently open trials in the same condition.

Other Jing Ma trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03905187.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing